Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2019

Open Access 01-12-2019 | Myasthenia Gravis | Research article

Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases

Authors: Devarajan Rathish, Minuri Karalliyadda

Published in: BMC Neurology | Issue 1/2019

Login to get access

Abstract

Background

Myasthenia gravis associated takotsubo syndrome is a rare condition. This study aimed to explore its typical presentation, investigations and treatment through a systematic review of previously reported cases.

Methods

Databases and reference lists of the selected articles were searched for case reports on Myasthenia gravis associated takotsubo syndrome. CARE guidelines were used for the quality assessment of the selected articles.

Results

Sixteen cases were selected out of 580 search results. Western Pacific, American and European regions contributed to 88% of the cases. Females were most affected (81%). Features of both myasthenia gravis and takotsubo syndrome were the common clinical presentations. All cases had a myasthenic crisis. Half of the cases had no prior diagnosis of myasthenia gravis. Pyridostigmine and prednisolone were useful for myasthenia gravis while dobutamine was most commonly used for takotsubo syndrome. All cases survived except four (25%).

Conclusions

Myasthenia gravis associated takotsubo syndrome via a myasthenic crisis is rare but life-threatening. Therefore, predisposition due to emotional and physical triggers needs to be avoided for its prevention. The rare entity should be suspected even in patients without a prior diagnosis of Myasthenia gravis.
Appendix
Available only for authorised users
Literature
1.
2.
McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004;55(4):580–4.PubMedCrossRef
3.
Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7(3):365–8.PubMedCrossRef
4.
Pevzner A, Schoser B, Peters K, Cosma N-C, Karakatsani A, Schalke B, et al. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol. 2012;259(3):427–35.PubMedCrossRef
5.
6.
Bedlack RS, Sanders DB. On the concept of myasthenic crisis. J Clin Neuromuscul Dis. 2002;4(1):40–2.PubMedCrossRef
7.
Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72(18):1548–54.PubMedCrossRef
8.
9.
10.
Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419–25.PubMedPubMedCentralCrossRef
11.
Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10:46.PubMedPubMedCentralCrossRef
12.
Hofstad H, Ohm OJ, Mørk SJ, Aarli JA. Heart disease in myasthenia gravis. Acta Neurol Scand. 1984;70(3):176–84.PubMedCrossRef
13.
Sakamoto A, Yamamoto M, Takahashi M, Ajiki K, Ota S, Murakami A, et al. A case of myasthenia gravis with cardiac fibrosis and easily provoked sustained ventricular tachycardia. J Cardiol Cases. 2010;2(1):e41–4.PubMedPubMedCentralCrossRef
14.
Vats HS, Richardson SK, Pulukurthy S, Olshansky B. Pericarditis in myasthenia gravis. Cardiol Rev. 2004;12(3):134–7.PubMedCrossRef
15.
HooKim K, DeRoux S, Igbokwe A, Stanek A, Koo J, Hsu J, et al. IgG anti-cardiomyocyte antibodies in giant cell myocarditis. Ann Clin Lab Sci. 2008;38(1):83–7.PubMed
16.
Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J. 2012;164(1):66–71.e1.PubMedCrossRef
17.
Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina pectoris-myocardial infarction investigations in Japan. J Am Coll Cardiol. 2001;38(1):11–8.PubMedCrossRef
18.
Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141(11):858–65.PubMedCrossRef
19.
Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. 1991;21(2):203–14.PubMed
20.
21.
Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol. 2015;12(7):387–97.PubMedCrossRef
22.
Finsterer J, Stöllberger C, Ho C-Y. Respiratory insufficiency from myasthenia gravis and polymyositis due to malignant thymoma triggering Takotsubo syndrome. Int J Neurosci. 2018;128(12):1207–1210.CrossRef
23.
Hugo ECH, Roberto DL, Benjamin PT, Rebeca VR, Emilio MI, Myrlene RB. Takotsubo syndrome associated with myasthenic crisis. A case report. Rev Mex Cardiol. 2016;27(3):123–9.
24.
John A, Singh S, Singh A, Lenneman CG. Reverse Takotsubo cardiomyopathy from myasthenic crisis: a case report. J Cardiovasc Dis Diagnosis. 2014;02(05):2–4.
25.
Thanaviratananich S, Katirji B, Alshekhlee A. Broken heart syndrome during myasthenic crisis. J Clin Neuromuscul Dis. 2014;15(3):90–5.PubMedCrossRef
26.
Finsterer J, Stöllberger C. Stress from myasthenic crisis triggers Takotsubo (broken heart) syndrome. Int J Cardiol. 2016;203:616–7.PubMedCrossRef
27.
28.
29.
30.
31.
Murai H, Utsugisawa K, Nagane Y, Suzuki S, Imai T, Motomura M. Rationale for the clinical guidelines for myasthenia gravis in Japan. Ann N Y Acad Sci. 2018;1413(1):35–40.PubMedCrossRef
32.
Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032–46.PubMedPubMedCentralCrossRef
33.
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Heal Med. 2013;2(5):38–43.CrossRef
34.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.PubMedPubMedCentralCrossRef
35.
Gao X, Zhu H. Stress cardiomyopathy in a patient with myasthenia gravis. Zhonghua Xin Xue Guan Bing Za Zhi. 2015;43(11):1004–5.PubMed
36.
Gautier P, Ravan R, Najjar M, Belhakem A, Ferrier N, Marcaggi X, et al. Syndrome Tako-tsubo au décours d’une perfusion d’immunoglobuline humaine normale (Tégeline®). Ann Cardiol Angeiol (Paris). 2011;60(5):290–5.CrossRef
37.
Rahmadiana. Komunikasi kesehatan: Sebuah tinjauan. J Psikogenes. 2012;1(1):88–94.
38.
Suzuki H. A 80-year-old woman with ST-segment elevation following sudden onset respiratory failure after Thymectomy in myasthenia gravis. Nihon Naika Gakkai Zasshi. 2011;100(4):1129–32.CrossRef
39.
Arai M, Ukigai H, Miyata H. A case of transient left ventricular ballooning (“Takotsubo”-shaped cardiomyopathy) developed during plasmapheresis for treatment of myasthenic crisis. Rinsho Shinkeigaku. 2004;44(3):207–10.PubMed
40.
Obón Azuara B, Ortas Nadal MR, Gutiérrez Cía I, Villanueva AB. Cardiomiopatía de Takotsubo: disfunción transitoria apical de ventrículo izquierdo. Med Int. 2007;31(3):146–52.
41.
Mayor-Gomez S, Lacruz F, Ezpeleta D. Myasthenic crisis and Takotsubo syndrome: a non-chance relationship. Rev Neurol. 2012;55(12):725–8.PubMed
42.
Finsterer J, Stöllberger C, Winkler WB. Metabolic myopathy facilitating the development of Takotsubo syndrome. Int J Cardiol. 2016;214:262–4.PubMedCrossRef
43.
Giallafos E, Zouvelou V, Maurogeni S, Stamboulis E. Subclinical cardiac involvement in thymomatous myasthenia gravis. Hell J Cardiol. 2016;57(5):345–7.CrossRef
44.
Drolet B, Gabra G, Simard C, Noël B, Poirier P. Verapamil-associated cardiogenic shock in a 71-year-old man with myasthenia gravis: a case report. J Med Case Rep. 2009;3(1):8219.PubMedPubMedCentralCrossRef
45.
Bansal V, Kansal MM, Rowin J. Broken heart syndrome in myasthenia gravis. Muscle Nerve. 2011;44(6):990–3.PubMedCrossRef
46.
Beydoun SR, Wang J, Levine RL, Farvid A. Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report. J Med Case Rep. 2010;4(1):393.PubMedPubMedCentralCrossRef
47.
Bijulal S, Harikrishnan S, Namboodiri N, Ajitkumar VK, Gupta D, Mathuranath PS. Tako-tsubo cardiomyopathy in a patient with myasthenia gravis crisis: a rare clinical association. Case Rep. 2009;2009:bcr0620080182.
48.
Hirose K, Yamaguchi H, Oshima Y, Choraku M, Hirono A, Takamori N, et al. Severe respiratory failure and torsades de pointes induced by disopyramide in a patient with myasthenia gravis. Intern Med. 2008;47(19):1703–8.PubMedCrossRef
49.
Padayachee L. Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy? Heart Lung Circ. 2007;16(Suppl 3):S65–70.PubMedCrossRef
50.
de Sousa JMA, Knobel M, Buchelle G, de Sousa JAM, Fisher CH, Born D, et al. Transient ventricular dysfunction (Takotsubo cardiomyopathy). Arq Bras Cardiol. 2005;84(4):340–2.PubMedCrossRef
51.
Battineni A, Mullaguri N, Thanki S, Chockalingam A, Govindarajan R. A case report of recurrent Takotsubo cardiomyopathy in a patient during myasthenia crisis. Case Rep Crit Care. 2017;2017:5702075.PubMedPubMedCentral
52.
Harries IB, Levoir H, Bucciarelli-Ducci C, Ramcharitar S. Takotsubo cardiomyopathy in myasthaenia gravis crisis confirmed by cardiac MRI. BMJ Case Rep. 2015;2015:2–5.
53.
Valbusa A, Ingrassia S, Rosa GM, Infante MT, Schenone A, Montecucco F, et al. Takotsubo cardiomyopathy and torsade de pointes in myasthenic crisis: be aware of QT prolongation. Am J Emerg Med. 2013;31(12):1717–8.PubMedCrossRef
54.
55.
Wong CP, Chia PL. Recurrent takotsubo cardiomyopathy precipitated by myasthenic crisis. Int J Cardiol. 2012;155(1):e11–2.PubMedCrossRef
56.
Nishinarita R, Kawamura Y, Yasuda T, Horikoshi Y, Ito D, Sugihara T, et al. A case of takotsubo cardiomyopathy leading to the diagnosis of myasthenia gravis. J Cardiol Cases. 2012;6(5):e141–4.PubMedPubMedCentralCrossRef
Metadata
Title
Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases
Authors
Devarajan Rathish
Minuri Karalliyadda
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2019
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-019-1523-z

Other articles of this Issue 1/2019

BMC Neurology 1/2019 Go to the issue

Study protocol

The evaluation of an online mindfulness program for people with multiple sclerosis: study protocol

Research article

An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study

Research article

One- to 10-year Status Epilepticus Mortality (SEM) score after 30 days of hospital discharge: development and validation using competing risks analysis

Correction

Correction to: ParkProTrain: an individualized, tablet-based physiotherapy training programme aimed at improving quality of life and participation restrictions in PD patients–a study protocol for a quasi-randomized, longitudinal and sequential multi-method study

Research article

Oligodendroglial tumours: subventricular zone involvement and seizure history are associated with CIC mutation status

Case report

Simultaneous cardio-cerebral embolization associated with atrial fibrillation: a case report